Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |